4//SEC Filing
Huang Jane 4
Accession 0001562180-24-007253
CIK 0001678660other
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 4:10 PM ET
Size
9.2 KB
Accession
0001562180-24-007253
Insider Transaction Report
Form 4
Huang Jane
President, CMO
Transactions
- Exercise/Conversion
Restricted Stock Unit
2024-10-04−9,375→ 56,250 total→ Common Stock (9,375 underlying) - Tax Payment
Common Stock
2024-10-04$2.00/sh−3,349$6,698→ 63,341 total - Exercise/Conversion
Common Stock
2024-10-04+9,375→ 66,690 total
Footnotes (3)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer's Common Stock.
- [F2]Represents shares withheld by the Issuer to satisfy the tax withholding obligation in connection with the vesting of RSUs.
- [F3]The RSUs were granted on May 2, 2022 and vest according to the reporting person's employment agreement. The RSUs vested as to 1/4 of the total shares on April 4, 2023, and 1/16 of the remaining shares shall vest quarterly thereafter until fully vested, subject to the continued service of the Reporting Person to the Issuer through each vesting date.
Documents
Issuer
Prelude Therapeutics Inc
CIK 0001678660
Entity typeother
Related Parties
1- filerCIK 0001683913
Filing Metadata
- Form type
- 4
- Filed
- Oct 6, 8:00 PM ET
- Accepted
- Oct 7, 4:10 PM ET
- Size
- 9.2 KB